GlucoTrack (NASDAQ:GCTK) specializes in the development of non-invasive glucose monitoring devices designed for people with diabetes and pre-diabetes. The company's flagship product, GlucoTrack, aims to eliminate the need for routine finger-prick blood tests by providing a pain-free method to measure blood glucose levels. Their technology is based on a combination of ultrasonic, electromagnetic, and thermal waves to analyze glucose in the body, offering a revolutionary approach to daily glucose monitoring. GlucoTrack's mission is to improve the quality of life for diabetics by providing an easy, painless way to keep track of their glucose levels, encouraging better disease management and control. The company is focused on research and development, aimed at enhancing the accuracy and user-friendliness of their devices, while also exploring new markets and opportunities for their cutting-edge technology.